Sapiens International (SPNS) has had the highest return since 2025 by a US stock with a market cap of $2,023+, returning 53,426.8%.
| ASSET | % RETURN |
|---|---|
Sapiens International (SPNS) | 53,426.82% |
Regencell Bioscience (RGC) | 20,139.52% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
FiEE (FIEE) | 1,638.53% |
NovaBay Pharmaceuticals (NBY) | 1,630.77% |
Abivax SA American Depositary Shares (ABVX) | 1,602.07% |
Oncology Institute (TOI) | 1,181.05% |
Hycroft Mining (HYMC) | 1,145.58% |
Zepp Health (ZEPP) | 1,038.46% |
DeFi Development (DFDV) | 879.34% |
Abits (ABTS) | 799.69% |
Diginex Limited Ordinary Shares (DGNX) | 754.46% |
Cidara Therapeutics (CDTX) | 716.38% |
Relmada Therapeutics (RLMD) | 715.34% |
Celcuity LLC (CELC) | 685.17% |
Sandisk (SNDK) | 681.75% |
Palvella Therapeutics (PVLA) | 661.76% |
AXT (AXTI) | 650.9% |
Terns Pharmaceuticals (TERN) | 594.86% |
Newegg Commerce (NEGG) | 594.75% |
Aimei Health Technology Co, Ltd Ordinary Share (AFJK) | 572.58% |
Nanobiotix (NBTX) | 571.7% |
Haoxi Health Technology Limited Class A Ordinary Shares (HAO) | 567.96% |
Almonty Industries Inc Common Shares (ALM) | 567.36% |
Avino Silver & Gold Mines (ASM) | 565.93% |
